EUVIMEDEUVIMED entdecken
Crossref

Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy

Gustavo Ferreira Araruna, Heber S C Ribeiro, Silvio M Torres, Alessandro L Diniz, André L Godoy, Igor C Farias, Wilson L Costa, Felipe J F Coimbra iD

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Gustavo Ferreira Araruna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Abdominal Surgery, A.C. Camargo Cancer Center, São Paulo, Brazil. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neoadjuvant Therapy, Gastrectomy, Minimally Invasive Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer is the fifth most common neoplasm and the third leading cause of cancer‐related death worldwide. Neoadjuvant chemotherapy is recommended for Stages II–III resectable tumors, but the comparative effectiveness of minimally invasive surgery (MIS) versus open gastrectomy (OG) post‐neoadjuvant therapy has not been adequately investigated.

Methods

A retrospective cohort analysis was performed on patients with clinical Stage II and III gastric adenocarcinoma who underwent neoadjuvant chemotherapy followed by either MIS or OG between 2007 and 2020. Propensity score matching was utilized to compare the clinical and surgical outcomes, morbidity, and mortality, and the influence of MIS on 3‐year survival rates was evaluated.

Results

After matching, no statistical differences in clinical aspects were noted between the two groups. MIS was associated with increased D2 lymphadenectomy, curative intent, and complete neoadjuvant therapy. Furthermore, this therapeutic approach resulted in reduced transfusion rates and shorter hospital stays. Nonetheless, no significant differences were observed in global, clinical, or surgical complications or mortality between the two groups. Weight loss emerged as a significant risk factor for complications, but MIS did not independently affect survival rates. Extended resection and higher American Society of Anesthesiology scores were independent predictors of reduced survival.

Conclusion

MIS after neoadjuvant chemotherapy for gastric cancer appears to be a viable option, with oncological outcomes comparable to those of OG, less blood loss, and shorter hospital stays. Although MIS did not independently affect long‐term survival, it offered potential benefits in terms of postoperative recovery and morbidity. Further studies are needed to validate these findings, especially across diverse populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsNeoadjuvant TherapyGastrectomyMinimally Invasive Surgical ProceduresHumansFemaleMaleRetrospective StudiesMiddle AgedSurvival RateAdenocarcinomaAgedChemotherapy, AdjuvantFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsPrognosis

Stichwörter der Autor:innen

gastric cancerminimally invasive surgeryneoadjuvant chemotherapysurgical outcomes

Autor:innen und Institutionen

  • Department of Abdominal Surgery, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Department of Medicine, Epidemiology, and Population Sciences, Dan L Duncan Comprehensive, Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Felipe J F Coimbra

Zitieren

APA

Araruna, G. F., Ribeiro, H. S. C., Torres, S. M., Diniz, A. L., Godoy, A. L., Farias, I. C., Costa, W. L., & Coimbra, F. J. F. (2024). Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27904

Vancouver

Araruna GF, Ribeiro HSC, Torres SM, Diniz AL, Godoy AL, Farias IC, et al. Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27904

BibTeX
@article{Araruna2024,
  author = {Araruna, Gustavo Ferreira and Ribeiro, Heber S C and Torres, Silvio M and Diniz, Alessandro L and Godoy, André L and Farias, Igor C and Costa, Wilson L and Coimbra, Felipe J F},
  title = {Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27904}
}
Kostenlos starten →